Documents to download

The Access to Palliative Care Bill [HL] is a private member’s bill introduced by Baroness Finlay of Llandaff (Crossbench). The bill had its first reading in the House of Lords on 5 July 2017. It is scheduled to receive its second reading on 14 June 2019.

Key Provisions

The bill aims to “make provision for clinical commissioning groups [CCGs] to ensure that persons in their area have access to specialist and generalist palliative care and appropriate support services”. If enacted, the bill would:

  • Require CCGs to ensure that individuals with palliative care needs have access to “appropriate health services”. This obligation would include, but not be limited to ensuring:
  • access to pain and symptom management;
  • psychological support for individuals and their relatives; and
  • information regarding an individual’s condition and palliative care.
  • Place a duty on CCGs to prepare and publish a strategy on providing for such palliative care needs. The strategy would have to set out information including the expected palliative care needs of adults and children in the relevant CCG’s area. Also, how these needs would be met; and under what circumstances and how specialist palliative care services would be provided.
  • The bill’s provisions would extend to England only.

    Background and Recent Developments

    Baroness Finlay introduced iterations of her Access to Palliative Care Bill [HL] in previous sessions. They were wider in scope than the current bill. The 2006–07 and 2015–16 versions completed their stages in the House of Lords before falling in the House of Commons. The 2016–17 version of the bill, meanwhile, did not progress beyond first reading.

    Speaking during the 2015–16 bill’s second reading debate, Baroness Finlay cited evidence that provision of palliative care in England was “unacceptably patchy”. She observed wide variation in the commissioned levels of palliative care services across the country. Baroness Finlay set out the case for a statutory duty on CCGs in relation to palliative care needs as follows:

    The demands on CCGs are great. They are well intentioned, but drowning. They need a clear, simple template to bring up the standard of services. Importantly, patients and their families, faced with all the fears and uncertainties of discovering that this is likely to be their final illness, need and deserve the assurance that their care will be good and that they will not be abandoned or failed in their hour of need, wherever they are, whatever the time or day of the week.

    Lord Hunt of King’s Heath, speaking in the debate on behalf of the Opposition, “warmly welcome[d]” the bill. However, Lord Prior of Brampton, Parliamentary Under Secretary at the Department of Health, stated that the Government could not support the bill. He said this was despite the Government being in “full agreement” with its underlying intentions. The “most important reason” for this was the Government’s view that palliative care was an issue “best tackled by clinicians, ideally together with patients, carers and loved ones”. This would be “based on a combination of the patient’s individual condition, [their] preferences and the clinician’s professional expertise”. Lord Prior added that the bill went “against the whole concept and principle of local autonomy that was established in primary legislation through the Health and Social Care Act 2012”. 

    More recently, the NHS Long Term Plan, published in January 2019, committed that the NHS would “introduce proactive and personalised care planning for everyone identified as being in their last year of life”. This would support a “reduction in avoidable emergency admissions and more people being able to die in a place they have chosen”. To deliver on this commitment, the Government has reiterated its view that ultimately the “funding and commissioning of palliative and end of life care is a local matter, over which individual NHS commissioners have responsibility”.

    Documents to download

    Related posts

    • Medicinal and agrochemical products can be granted a Supplementary Protection Certificate, an intellectual property right associated with patents, to provide up to five years of additional rights and protections once their patents have expired. In order to apply for an SPC, a product must receive approval to be sold on the UK market. Under the Northern Ireland/Ireland Protocol, products to be sold in Northern Ireland must obtain approval under EU law, whilst products to be sold in the rest of the UK will obtain approval under UK law. Currently, this marketing authorisation is only given on a UK-wide basis. This regulation amends the market authorisation process to enable authorisations to be granted for the Northern Ireland market only and for the Great Britain market only.

    • There is currently a system for mutual recognition of health and social care qualifications within and between European Economic Area states and Switzerland. The UK has passed legislation amending its provisions in this area to take account of its exit from the EU. In recent agreements with Switzerland and the European Free Trade Area states, the UK committed to conditions for these countries which go further than the legislation that has already been passed. The European Qualifications (Health and Social Care Professions) (EFTA States) (Amendment etc.) (EU Exit) Regulations 2020 would implement these commitments.

    • The UK will no longer be part of EU reciprocal and cross-border healthcare arrangements after the transition period ends on 31 December 2020. However, some groups of people will retain rights after this under the terms of the withdrawal agreement. The Government made regulations in 2019 to deal with reciprocal and cross-border healthcare if the UK left the EU with no ‘divorce’ deal. It is now planning to update these regulations to reflect the withdrawal agreement.